PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
PYXS Pyxis Oncology
- 1.320
- +0.020+1.54%
Close Feb 14 16:00 ET
- 1.319
- -0.001-0.09%
Post 19:59 ET
78.49MMarket Cap-1.25P/E (TTM)
1.350High1.265Low821.65KVolume1.310Open1.300Pre Close1.08MTurnover2.29%Turnover RatioLossP/E (Static)59.47MShares6.85052wk High0.51P/B47.46MFloat Cap1.23052wk Low--Dividend TTM35.95MShs Float19.000Historical High--Div YieldTTM6.54%Amplitude1.100Historical Low1.312Avg Price1Lot Size
Pyxis Oncology News
Pyxis Oncology | 424B2: Prospectus
Pyxis Oncology | EFFECT: Others
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | EFFECT: Others
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Pyxis Oncology | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144
Pyxis Oncology | EFFECT: Others
Pyxis Oncology | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Pyxis Oncology | 424B3: Prospectus
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?